Champions Oncology Inc Stock Ownership - Who owns Champions Oncology?

Insider buying vs selling

Have Champions Oncology Inc insiders been buying or selling?
Daniel Newman MendelsonDirector2024-01-121,000$6.50
Daniel Newman MendelsonDirector2024-01-112,000$6.27
Daniel Newman MendelsonDirector2024-01-102,944$6.31
Daniel Newman MendelsonDirector2024-01-093,000$6.25
Daniel Newman MendelsonDirector2024-01-081,000$6.15
Daniel Newman MendelsonDirector2024-01-052,000$6.09
Daniel Newman MendelsonDirector2024-01-043,000$6.12
Daniel Newman MendelsonDirector2024-01-03500$5.83
Daniel Newman MendelsonDirector2023-12-212,500$4.92
Daniel Newman MendelsonDirector2023-12-202,100$4.82

1 of 3

CSBR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CSBR insiders and whales buy or sell their stock.

CSBR Shareholders

What type of owners hold Champions Oncology Inc stock?
Michael Maurice Brown172.45%23,442,589$118.62MInsider
Anthony A. Florence Jr.137.93%18,750,000$94.88MInsider
Scott D. Sandell137.93%18,750,000$94.88MInsider
Peter W. Sonsini137.93%18,750,000$94.88MInsider
Ravi Viswanathan137.93%18,750,000$94.88MInsider
Harry R. Weller137.93%18,750,000$94.88MInsider
M. James Barrett137.93%18,750,000$94.88MInsider
Peter J. Barris137.93%18,750,000$94.88MInsider
Forest Baskett137.93%18,750,000$94.88MInsider
David M. Mott137.93%18,750,000$94.88MInsider

1 of 3

CSBR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CSBR1.91%98.09%Net Buying
ALRN4.75%95.25%Net SellingNet Selling
CVM13.82%40.65%Net BuyingNet Buying
ENTX11.90%3.97%Net Buying

Champions Oncology Stock Ownership FAQ

Who owns Champions Oncology?

Champions Oncology (NASDAQ: CSBR) is owned by 41.44% institutional shareholders, 2,128.69% Champions Oncology insiders, and 0.00% retail investors. Michael Maurice Brown is the largest individual Champions Oncology shareholder, owning 23.44M shares representing 172.45% of the company. Michael Maurice Brown's Champions Oncology shares are currently valued at $118.62M.

If you're new to stock investing, here's how to buy Champions Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.